The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma

R. Buhl (Mainz, Germany)

Source: International Congress 2017 – Bronchial asthma management
Session: Bronchial asthma management
Session type: Thematic Poster
Number: 659
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Buhl (Mainz, Germany). The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma. 659

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A clinical and outcomes assessment of the management of acute episodes of chronic bronchitis (AECB) : the MOSAIC study - baseline characteristics of screened patients
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002

Patients with persistent asthma may have poor disease control despite normal lung function: baseline data from a pan-European real-life study
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009

MARTE: an observational study on clinical and sociodemographic characteristics of asthmatic patients receiving maintenance and rescue treatment in Spain
Source: International Congress 2018 – Asthma: clinical screening tools
Year: 2018

Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study)
Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015
Year: 2017



Characteristics and outcomes of chronic cough in individuals with asthma: a population-based study
Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Year: 2018




A comparison of the management of COPD exacerbations in six European hospitals: demographics and baseline data
Source: Annual Congress 2008 - Management of COPD
Year: 2008



Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR)
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018

Baseline characteristics of patients admitted for the first time for COPD exacerbation. The ²phenotype and course of COPD² (PAC-COPD) study
Source: Annual Congress 2007 - Epidemiology of COPD
Year: 2007


Patients' experiences of asthma exacerbation and management: a qualitative study of severe asthma
Source: ERJ Open Res, 7 (2) 00528-2020; 10.1183/23120541.00528-2020
Year: 2021



LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study
Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura
Year: 2013


Spanish study on unmet clinical needs in patients with uncontrolled severe asthma.
Source: International Congress 2018 – Asthma management
Year: 2018




Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009


Gender differences in health status in patients with COPD: baseline characteristics of a multi-centre intervention and characterisation study on Seretide (COSMIC)
Source: Eur Respir J 2002; 20: Suppl. 38, 262s
Year: 2002

Asthma health status is better reflected by asthma control than by asthma severity in Asian patients - a prospective study
Source: Eur Respir J 2003; 22: Suppl. 45, 284s
Year: 2003

Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR)
Source: Eur Respir J, 52 (2) 1701927; 10.1183/13993003.01927-2017
Year: 2018



Baseline characteristics of severe asthma patients initiating biologic treatment worldwide
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019


Characteristics of a cohort of patients with work related asthma in a monographic consultation of asthma.
Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases
Year: 2019


Asthma control in patients with different severity degrees of asthma in primary care and the effect of a self-management program on asthma control – an observational study
Source: Eur Respir J 2005; 26: Suppl. 49, 671s
Year: 2005

Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021